---
title: "Stifel Nicolaus Sticks to Their Buy Rating for Alphatec Holdings (ATEC)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285877120.md"
description: "Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on Alphatec Holdings (ATEC) with a price target of $16.00. The stock closed at $7.52. The analyst has a 5.1% average return and a 40.91% success rate. The overall analyst consensus for Alphatec is a Strong Buy, with an average price target of $18.91, indicating a potential upside of 151.46%. H.C. Wainwright also reiterated a Buy rating with a $24.00 price target."
datetime: "2026-05-11T02:35:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285877120.md)
  - [en](https://longbridge.com/en/news/285877120.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285877120.md)
---

# Stifel Nicolaus Sticks to Their Buy Rating for Alphatec Holdings (ATEC)

Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on Alphatec Holdings on May 8 and set a price target of $16.00. The company’s shares closed last Friday at $7.52.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Stephan is a 3-star analyst with an average return of 5.1% and a 40.91% success rate. Stephan covers the Healthcare sector, focusing on stocks such as TransMedics Group, Alphatec Holdings, and Bausch + Lomb Corporation.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alphatec Holdings with a $18.91 average price target, which is a 151.46% upside from current levels. In a report released on May 7, H.C. Wainwright also reiterated a Buy rating on the stock with a $24.00 price target.

### Related Stocks

- [ATEC.US](https://longbridge.com/en/quote/ATEC.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [TMDX.US](https://longbridge.com/en/quote/TMDX.US.md)
- [BLCO.US](https://longbridge.com/en/quote/BLCO.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.](https://longbridge.com/en/news/286975809.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)
- [Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)](https://longbridge.com/en/news/286443716.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Stifel Nicolaus Sticks to Its Buy Rating for Becton Dickinson (BDX)](https://longbridge.com/en/news/285875450.md)